全文获取类型
收费全文 | 10802篇 |
免费 | 824篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 145篇 |
儿科学 | 196篇 |
妇产科学 | 152篇 |
基础医学 | 1173篇 |
口腔科学 | 104篇 |
临床医学 | 1059篇 |
内科学 | 2147篇 |
皮肤病学 | 129篇 |
神经病学 | 839篇 |
特种医学 | 377篇 |
外科学 | 2071篇 |
综合类 | 125篇 |
一般理论 | 11篇 |
预防医学 | 811篇 |
眼科学 | 931篇 |
药学 | 616篇 |
中国医学 | 12篇 |
肿瘤学 | 767篇 |
出版年
2024年 | 15篇 |
2023年 | 151篇 |
2022年 | 224篇 |
2021年 | 585篇 |
2020年 | 299篇 |
2019年 | 486篇 |
2018年 | 543篇 |
2017年 | 361篇 |
2016年 | 366篇 |
2015年 | 395篇 |
2014年 | 555篇 |
2013年 | 652篇 |
2012年 | 976篇 |
2011年 | 903篇 |
2010年 | 502篇 |
2009年 | 402篇 |
2008年 | 596篇 |
2007年 | 581篇 |
2006年 | 510篇 |
2005年 | 468篇 |
2004年 | 407篇 |
2003年 | 347篇 |
2002年 | 247篇 |
2001年 | 62篇 |
2000年 | 17篇 |
1999年 | 33篇 |
1998年 | 89篇 |
1997年 | 78篇 |
1996年 | 75篇 |
1995年 | 63篇 |
1994年 | 62篇 |
1993年 | 49篇 |
1992年 | 52篇 |
1991年 | 57篇 |
1990年 | 57篇 |
1989年 | 57篇 |
1988年 | 54篇 |
1987年 | 9篇 |
1986年 | 39篇 |
1985年 | 35篇 |
1984年 | 46篇 |
1983年 | 45篇 |
1982年 | 31篇 |
1981年 | 20篇 |
1980年 | 4篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1976年 | 9篇 |
1955年 | 3篇 |
1954年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Janet Li Paul Roche Jenean Spencer Ivan Bastian Amanda Christensen Mark Hurwitz Anastasios Konstantinos Vicki Krause Moira McKinnon Avner Misrachi Graham Tallis Justin Waring 《Communicable diseases intelligence》2004,28(4):464-473
The National Notifiable Disease Surveillance System (NNDSS) received 982 tuberculosis (TB) notifications in 2003, of which 947 were new cases, 33 were relapses and two were cases with unknown history. The incidence of TB in Australia has remained at a stable rate since 1985 and was 4.9 cases per 100,000 population in 2003. The high-incidence groups remain people born overseas and Indigenous Australians at 19.9 and 8.7 cases per 100,000 population, respectively. By contrast the incidence in non-Indigenous Australians was 0.9 per 100,000. Comparison of the 2003 TB notification data against the performance indicators set by National Tuberculosis Advisory Committee highlights that enhanced TB control measures should be considered among these high-risk groups. 相似文献
102.
Louis B Cooper Dylan K Chan Frederick C Roediger Brian R Shaffer Justin F Fraser Sergei Musatov Samuel H Selesnick Michael G Kaplitt 《Otology & neurotology》2006,27(4):484-490
HYPOTHESIS: Delivery of the gene encoding X-linked inhibitor of apoptosis (XIAP) using an adeno-associated viral (AAV) vector can protect against cisplatin-mediated ototoxicity. BACKGROUND: Cisplatin is a widely used chemotherapeutic agent with significant ototoxic side effects. One possible mechanism of toxicity is apoptotic death of many cochlear cell types. Acute treatment with inhibitors of caspases- enzymes critical for apoptosis- has been shown to prevent hearing loss in vivo, but is too short-acting for therapeutic use. Gene therapy provides a specific and chronic means of delivering potential therapeutic gents. Introducing an anti-apoptotic gene into the cochlea could provide long-term prophylaxis against the ototoxic effects of cisplatin. METHOD: Two groups of rats were treated with unilateral injection into the round window of AAV harboring a gene encoding either XIAP or green fluorescent protein (GFP). After at least two months of gene expression, auditory-brainstem-response (ABR) threshold shifts and outer-hair-cell (OHC) number were measured in these two groups of animals after 72-hour treatment with cisplatin. RESULTS: Consistent with previous reports, uninjected and AAV.GFP-injected ears displayed profound ABR threshold elevations and OHC loss after cisplatin treatment. Ears that had been injected with AAV encoding XIAP, however, were significantly protected from these effects: cisplatin-induced ABR-threshold shift and hair-cell loss were attenuated by as much as 78% and 45%, respectively, when compared with contralateral (untreated) ears. CONCLUSION: XIAP delivery to the cochlea can protect against the audiometric changes and hair-cell loss associated with cisplatin ototoxicity. The efficacy, specificity, and duration of the protective effects make this a potentially attractive therapeutic paradigm. 相似文献
103.
Dan W Haupt Angela Luber Justin Maeda Angela K Melson Julie A Schweiger John W Newcomer 《Neuropsychopharmacology》2005,30(1):184-191
Alterations in plasma leptin have been reported in schizophrenia patients treated with antipsychotics, suggesting the hypothesis that impairments in leptin secretion or signaling might play a role in antipsychotic-induced weight gain. Plasma leptin was measured in 72 schizophrenia patients chronically treated with olanzapine (n=27), risperidone (n=24) or typical antipsychotics (n=21) and 124 healthy adult control subjects. ANCOVA was used to test effects of adiposity (body mass index kg/m2; BMI), subject group (treated patients vs untreated controls), and treatment group (specific medication groups and untreated controls) on plasma leptin concentrations. Additional analyses were performed in a subset of patients and controls individually matched for BMI to further assess group differences in plasma leptin independent of adiposity. BMI strongly predicted plasma leptin concentrations in the overall sample. In addition, a significant three-way interaction between BMI, subject group, and gender was observed. In the individually BMI-matched sample, modestly reduced plasma leptin levels (effect size 0.4 SD) were observed in treated patients in comparison to the BMI-matched healthy controls, with both groups including males and females. However, no differences in plasma leptin levels were observed in the matched sample when separately comparing male patients vs untreated male controls and female patients vs untreated female controls. Plasma leptin in chronically treated patients with schizophrenia is strongly predicted by adiposity, similar to untreated healthy individuals despite adequate power to detect a difference. The results argue against a role for defective leptin secretion or sensitivity in the weight gain induced by antipsychotic medications. 相似文献
104.
Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor. 总被引:7,自引:0,他引:7
E Ramsay Camp Justin Summy Todd W Bauer Wenbiao Liu Gary E Gallick Lee M Ellis 《Clinical cancer research》2005,11(1):397-405
Targeted therapies that inhibit the activity of tyrosine kinase receptors such as the epidermal growth factor receptor (EGFR) have shown activity against solid malignancies when used as single agents or in combination with chemotherapy. Although anti-EGFR therapies are active in some patients, eventually disease in nearly all patients will become refractory to therapy. Therefore, a better understanding of the mechanisms of resistance to anti-EGFR therapies is critical to further improve the efficacy of this class of agents. Mechanisms that mediate resistance to anti-EGFR therapies include the presence of redundant tyrosine kinase receptors, increased angiogenesis, and the constitutive activation of downstream mediators. Two recent landmark publications have also shown that specific mutations in the kinase domain of EGFR in some lung carcinomas are associated with markedly improved response rates to an EGFR tyrosine kinase inhibitor. Mutations in the EGFR receptor seem to play a significant role in determining the sensitivity of tumor cells to EGFR inhibitor therapy by altering the conformation and activity of the receptor. As the field of molecular therapeutics continues to evolve, a comprehensive understanding of resistance mechanisms will ultimately lead to refinements in our regimens to provide better care for patients with cancer. 相似文献
105.
106.
107.
108.
Matthew P. Caley Helen King Neel Shah Kai Wang Mercedes Rodriguez-Teja Julian H. Gronau Jonathan Waxman Justin Sturge 《Clinical & experimental metastasis》2016,33(2):151-165
The diverse composition and structure of extracellular matrix (ECM) interfaces encountered by tumor cells at secondary tissue sites can influence metastatic progression. Extensive in vitro and in vivo data has confirmed that metastasizing tumor cells can adopt different migratory modes in response to their microenvironment. Here we present a model that uses human stromal cell-derived matrices to demonstrate that plasticity in tumor cell movement is controlled by the tumor-associated collagen receptor Endo180 (CD280, CLEC13E, KIAA0709, MRC2, TEM9, uPARAP) and the crosslinking of collagen fibers by stromal-derived lysyl oxidase (LOX). Human osteoblast-derived and fibroblast-derived ECM supported a rounded ‘amoeboid-like’ mode of cell migration and enhanced Endo180 expression in three prostate cancer cell lines (PC3, VCaP, DU145). Genetic silencing of Endo180 reverted PC3 cells from their rounded mode of migration towards a bipolar ‘mesenchymal-like’ mode of migration and blocked their translocation on human fibroblast-derived and osteoblast-derived matrices. The concomitant decrease in PC3 cell migration and increase in Endo180 expression induced by stromal LOX inhibition indicates that the Endo180-dependent rounded mode of prostate cancer cell migration requires ECM crosslinking. In conclusion, this study introduces a realistic in vitro model for the study of metastatic prostate cancer cell plasticity and pinpoints the cooperation between tumor-associated Endo180 and the stiff microenvironment imposed by stromal-derived LOX as a potential target for limiting metastatic progression in prostate cancer. 相似文献
109.
110.
Reproducibility of Echocardiograph‐Derived Multilevel Left Ventricular Apical Twist Mechanics 下载免费PDF全文
Glenn M. Stewart B.Ex.Sc. Akira Yamada M.D. Ph.D. Justin J. Kavanagh Ph.D. Luke J. Haseler M.Phil. Ph.D. Surendran Sabapathy Ph.D. 《Echocardiography (Mount Kisco, N.Y.)》2016,33(2):257-263
Left ventricular (LV) twist mechanics are routinely assessed via echocardiography in clinical and research trials investigating the function of obliquely oriented myocardial fibers. However, echocardiograph‐derived measures of LV twist may be compromised by nonstandardized acquisition of the apical image. This study examined the reproducibility of echocardiograph‐derived parameters of apical twist mechanics at multiple levels of the apical myocardium. Two sets of 2D LV parasternal short‐axis images were obtained in 30 healthy subjects (24 men; 19–57 year) via echocardiography. Images were acquired immediately distal to the papillary muscles (apical image 1), immediately above the point of LV cavity obliteration at end systole (apical image 3), and midway between apical image 1 and apical image 3 (apical image 2). Repeat scans were performed within 1 hour, and twist mechanics (rotation and rotation rate) were calculated via frame‐by‐frame tracking of natural acoustic echocardiographic markers (speckle tracking). The magnitude of apical rotation increased progressively toward the apex (apical image 1: 4.2 ± 2.1°, apical image 2: 7.2 ± 3.9°, apical image 3: 11.8 ± 4.6°). apical images 1, 2, and 3 each had moderate to good correlations between repeat scans (ICC: 0.531–0.856). When apical images 1, 2, and 3 were averaged, rotation was 7.7 ± 2.7° and between‐scan correlation was excellent (ICC: 0.910). Similar results were observed for systolic and diastolic rotation rates. Averaging multiple standardized apical images, tending progressively toward the apex, generated the most reproducible rotation indices and may be optimal for the assessment of LV twist mechanics across therapeutic, interventional, and research studies; however, care should be taken given the influence of acquisition level on the magnitude of apical rotation. 相似文献